N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9
Stock Status: Enquire
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-T-96370
Research Use
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9 Product Information
N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9 is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96370.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9
CAS No.
-
CAT No.
CS-T-96370
Molecular Formula
C29H23D9N2O4
Molecular Weight
481.63
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9"
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9 is the isotope labelled analog of N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine. N2-Des(L-valinyl) Lopinavir N2,O5-oxazine is a metabolite of Lopinavir (L469480); a selective HIV protease inhibitor and antiviral. It is a COVID19-related research product."
Synonyms
"N-((S)-1-((4S,6S)-4-Benzyl-2-oxo-1,3-oxazinan-6-yl)-2-phenylethyl)-2-(2,6-dimethylphenoxy)acetamide-d9"
Application Notes
"N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9 is the isotope labelled analog of N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine. N2-Des(L-valinyl) Lopinavir N2,O5-oxazine is a metabolite of Lopinavir (L469480); a selective HIV protease inhibitor and antiviral. It is a COVID19-related research product."
References
"Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998); Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999); Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)"